CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company
Chemomab Therapeutics Ltd.
Sign in to watch- Ticker
- CMMB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- EIN
- 813676773
- Phone
- 972-77-331-0156
- Business address
- KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
- Former names
- Anchiano Therapeutics Ltd., BioCancell Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,516
- in 1 filing
Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Mor George Adi Chief Scientific Officer | Sale | −7,700 | $5.03 | $39K | 317,075 |
| 2023-01-03 | Mor George Adi Chief Scientific Officer | Sale | −6,100 | $5.03 | $31K | 251,147 |
| 2023-01-03 | OrbiMed Israel GP Ltd. 10% owner | Sale | −266,376 | $3.34 | $890K | 2,311,798 |
| 2023-01-03 | OrbiMed Israel GP Ltd. 10% owner | Sale | −70,524 | $4.51 | $318K | 2,241,274 |
| 2022-11-16 | Cohen Neil Harris Director | Sale | −2,409 | $2.00 | $5K | 10,000 |
| 2022-11-16 | Mor George Adi Chief Scientific Officer | Sale | −324,775 | $2.08 | $677K | 324,775 |
| 2022-11-16 | Mor George Adi Chief Scientific Officer | Sale | −257,248 | $2.08 | $536K | 257,247 |
| 2022-11-08 | Fatal Sigal Chief Financial Officer | Grant or award · Option to Purchase American Depositary Shares | +29,400 | 65,000 | ||
| 2022-06-16 | Quigley Jill M. Director | Grant or award · Option to Purchase American Depositary Shares | +13,640 | 13,640 | ||
| 2022-05-24 | Maryles Joel Michael Director | Purchase | +400 | $2.89 | $1K | 1,400 |
| 2022-05-24 | Maryles Joel Michael Director | Purchase | +33 | $2.76 | $91 | 1,433 |
| 2022-05-18 | Cohen Neil Harris Director | Purchase | +2,000 | $3.19 | $6K | 12,409 |
| 2022-03-18 | Maryles Joel Michael Director | Purchase | +500 | $4.32 | $2K | 500 |
| 2022-03-18 | Maryles Joel Michael Director | Purchase | +500 | $4.36 | $2K | 1,000 |
| 2022-03-16 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.30 | $825 | 1,750 |
| 2022-03-16 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.25 | $813 | 2,000 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.00 | $1K | 250 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.98 | $995 | 500 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $3.90 | $975 | 1,000 |
| 2022-03-14 | Marvin Donald Executive VP, CFO & COO | Purchase | +250 | $4.10 | $1K | 1,250 |
Page 2 of 6 · 110 trades